You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced UC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ulcerative Colitis Trial (Appendectomy, Infliximab)

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jun 27, 2023

Adult Solid Tumor, Advanced Solid Tumor, Refractory Tumor Trial in Bruxelles, Edegem, Rotterdam (DO-2)

Recruiting
  • Adult Solid Tumor
  • +2 more
  • Bruxelles, Belgium
  • +2 more
Mar 1, 2023

Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • ET140203 autologous T cell product
  • Duarte, California
  • +3 more
Jul 1, 2022

Hemophilia B Trial in Worldwide (PF-06838435 (formerly SPK-9001))

Recruiting
  • Hemophilia B
  • PF-06838435 (formerly SPK-9001)
  • Sacramento, California
  • +24 more
Feb 2, 2023

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • CRX100 suspension for infusion
  • Scottsdale, Arizona
  • +2 more
Jul 26, 2022

Breast Tumors Trial in La Jolla (Cirmtuzumab + Paclitaxel)

Active, not recruiting
  • Breast Neoplasms
  • Cirmtuzumab + Paclitaxel
  • La Jolla, California
    University of California, San Diego
May 16, 2022

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

Hemophilia A Trial in United States (SB-525 (PF-07055480))

Active, not recruiting
  • Hemophilia A
  • SB-525 (PF-07055480)
  • Little Rock, Arkansas
  • +19 more
Sep 19, 2022

Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • La Jolla, California
  • +4 more
Aug 9, 2022

Melanoma Trial in United States (CAVATAK, Ipilimumab)

Completed
  • Melanoma
  • Duarte, California
  • +10 more
Jan 12, 2023

Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,

Completed
Has Results
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Cabozantinib S-malate
  • +2 more
  • La Jolla, California
  • +19 more
Dec 14, 2022

Adult Solid Tumor Trial in Spain, United States (SQZ-AAC-HPV, Ipilimumab, Nivolumab)

Recruiting
  • Adult Solid Tumor
  • SQZ-AAC-HPV
  • +2 more
  • Duarte, California
  • +5 more
Aug 12, 2022

Renal Cell Carcinoma (RCC), Urothelial Carcinoma, Primary Peritoneal Cancer Trial in Canada, United States (DSP-7888 Dosing

Completed
  • Renal Cell Carcinoma (RCC)
  • +5 more
  • DSP-7888 Dosing Emulsion
  • +2 more
  • Tucson, Arizona
  • +18 more
Dec 6, 2022

HER2-expressing Cancers Trial in United States (Zanidatamab, Evorpacept)

Recruiting
  • HER2-expressing Cancers
  • Birmingham, Alabama
  • +11 more
Apr 8, 2022

Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))

Active, not recruiting
Has Results
  • Advanced Solid Tumors
  • DS-8201a (DP1)
  • +2 more
  • San Diego, California
  • +13 more
Oct 4, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +7 more
  • La Jolla, California
    UC San Diego Moores Cancer Center
Jul 20, 2022

Advanced or Metastatic Solid Tumor Malignancies Trial in United States (NP-G2-044 Monotherapy, Anti-PD-(L)1 Therapy, NP-G2-044

Recruiting
  • Advanced or Metastatic Solid Tumor Malignancies
  • NP-G2-044 Monotherapy
  • +2 more
  • Scottsdale, Arizona
  • +14 more
Jan 5, 2023

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)

Active, not recruiting
  • Stage III Ovarian Carcinoma
  • +3 more
  • AVOVA-1
  • MC
  • Burbank, California
  • +5 more
Apr 21, 2022

Liver Diseases, Alcohol Use Disorder Trial in San Francisco (Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use,

Not yet recruiting
  • Liver Diseases
  • Alcohol Use Disorder
  • Stepped alcohol intervention (SAT) to reduce unhealthy alcohol use
  • Usual Care (UC)
  • San Francisco, California
    University of california San Francisco
Feb 22, 2022

Advance Care Planning, Advance Directives, Advanced Cancer Trial in Irvine, Los Angeles, San Francisco (Advance directive,

Active, not recruiting
  • Advance Care Planning
  • +2 more
  • Advance directive
  • +2 more
  • Irvine, California
  • +2 more
Sep 29, 2021

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)

Active, not recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
  • +1 more
Apr 4, 2022